Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole M Kuderer

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Frontiers in Immunology|November 28, 2022
Predictive models for thromboembolic events in giant cell arteritis: A US veterans health administration population-based studyDespina Michailidou, Tianyu Zhang, Nicole M Kuderer, et al.
Thrombosis Research|August 5, 2010
Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapyGregory C Connolly, Alok A Khorana, Nicole M Kuderer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Thromboembolism in hospitalized neutropenic cancer patientsAlok A Khorana, Charles W Francis, Eva Culakova, et al.
Pharmacoeconomics|April 4, 2007
Therapeutic use of granulocyte colony-stimulating factors for established febrile neutropenia: effect on costs from a hospital perspectiveLeon E Cosler, Adi Eldar-Lissai, Eva Culakova, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2008
Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practiceJeffrey Crawford, David C Dale, Nicole M Kuderer, et al.
Blood Advances|August 28, 2020
Effectiveness and safety of rivaroxaban compared with low-molecular-weight heparin in cancer-associated thromboembolismOlivia S Costa, Christine G Kohn, Nicole M Kuderer, et al.
Clinical and Molecular Allergy : CMA|January 20, 2004
Mite and cockroach proteases activate p44/p42 MAP kinases in human lung epithelial cellsNicole M Kuderer, Homero G San-Juan-Vergara, Xiaoyuan Kong, et al.
Cancer|April 22, 2011
Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapyGary H Lyman, Nicole M Kuderer, Jeffrey Crawford, et al.
Journal of Thrombosis and Haemostasis : JTH|August 18, 2019
Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta-analysisAng Li, Nicole M Kuderer, David A Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2010
Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic reviewGary H Lyman, David C Dale, Debra A Wolff, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|November 28, 2022
Predictive models for thromboembolic events in giant cell arteritis: A US veterans health administration population-based studyDespina Michailidou, Tianyu Zhang, Nicole M Kuderer, et al.
Thrombosis Research|August 5, 2010
Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapyGregory C Connolly, Alok A Khorana, Nicole M Kuderer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Thromboembolism in hospitalized neutropenic cancer patientsAlok A Khorana, Charles W Francis, Eva Culakova, et al.
Pharmacoeconomics|April 4, 2007
Therapeutic use of granulocyte colony-stimulating factors for established febrile neutropenia: effect on costs from a hospital perspectiveLeon E Cosler, Adi Eldar-Lissai, Eva Culakova, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2008
Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practiceJeffrey Crawford, David C Dale, Nicole M Kuderer, et al.
Blood Advances|August 28, 2020
Effectiveness and safety of rivaroxaban compared with low-molecular-weight heparin in cancer-associated thromboembolismOlivia S Costa, Christine G Kohn, Nicole M Kuderer, et al.
Clinical and Molecular Allergy : CMA|January 20, 2004
Mite and cockroach proteases activate p44/p42 MAP kinases in human lung epithelial cellsNicole M Kuderer, Homero G San-Juan-Vergara, Xiaoyuan Kong, et al.
Cancer|April 22, 2011
Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapyGary H Lyman, Nicole M Kuderer, Jeffrey Crawford, et al.
Journal of Thrombosis and Haemostasis : JTH|August 18, 2019
Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta-analysisAng Li, Nicole M Kuderer, David A Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2010
Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic reviewGary H Lyman, David C Dale, Debra A Wolff, et al.
Pageof 9